The Models behind growth of Indias Pharma Overseas Industry

India’s pharma story is more than generics and vaccines — it’s about adaptable business models that enabled us to serve the world, efficiently and affordably. Over the last decade, India’s pharma industry has: Behind this rapid growth is a mix of operating models like loan license, third-party, CROs, CMOs, CDMOs, CRAMS, etc. While many of […]

India’s Rising CDMO Powerhouse – A Perspective from APDM

The Indian pharmaceutical industry has long been recognized for its cost-competitive manufacturing capabilities, production scale, and extensive global market reach. Over the last decade, companies in India have increasingly pivoted toward contract development and manufacturing services (CDMO), offering a broad suite of research and manufacturing solutions to customers around the world. For APDM, which monitors […]

AI and the Pharmaceutical Revolution: An APDM Narrative

Early one morning, Dr. Felicia Grant glanced at the digital clock on her lab station at APDM Research Labs. The sun had barely risen, but her AI-assisted software was already buzzing with new molecular leads. She sipped her coffee, recalling the day she first dreamt of creating treatments that could fundamentally change lives. Back then, […]

Sustainability in Biotechnology: Shaping a Greener Future for Pharma

Introduction: The Need for Sustainability in Pharma The pharmaceutical industry has long been known for its groundbreaking research, drug development, and life-saving therapies. However, these advancements have traditionally come with a significant environmental impact, characterized by high energy consumption, chemical waste, and resource-intensive processes. As the global focus shifts toward eco-conscious practices, integrating sustainable methods […]